Choosing between biotech giants Biogen(NASDAQ:BIIB) and Amgen(NASDAQ:AMGN) is not an easy task. Both companies have attractive pipelines and solid suites of products on the market. Though Amgen’s revenue declined in 2019 while Biogen’s rose, Amgen offered a b…
Read More
Post Date: March 15, 2020